Floatz logo

[225ac]ac-a9-3408

Mucosal Melanoma

Alpha-9 Oncology USA Inc.Phase 1Active
CC
41/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
81/ 100

Competitive context

32 Active assets in the Mucosal Melanoma cohort.

Asset / SponsorPhaseRating
Pembrolizumab
Melanoma Institute Australia
Phase 3BB
Tyrosinase Peptide
University of Southern California
Phase 3BB
INTERFERON ALFA-2B
Shanghai Junshi Bioscience Co., Ltd.
Phase 3B
Ifa
Craig L Slingluff, Jr
Phase 2B
Nilotinib
Institute of Cancer Research, United Kingdom
Phase 2B

View all 50 →

Same molecule, other indications

[225ac]ac-a9-3408 is also rated in:

metastatic melanomaDormant
CC
Indicative ·
43 / 100
View asset →
uveal melanomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →